Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

1(33.3%)

Phase 4

1(33.3%)

Phase 2

1(33.3%)

3Total

N/A(1)

Phase 4(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT03042858Active Not Recruiting

Natural History of Infants With Patent Processus Vaginalis

Role: collaborator

NCT04400071Not ApplicableCompleted

Biology and Benefits of Music Play and Stories for Kids/Parents During ALL Treatment

Role: collaborator

NCT05561764Phase 4Terminated

Imipenem/Cilastatin/Relebactam Pharmacokinetics, Safety, and Outcomes in Adults and Adolescents With Cystic Fibrosis

Role: collaborator

NCT02271932Unknown

Multi-institutional Trial of Non-operative Management of Appendicitis

Role: collaborator

NCT00004787Phase 2Completed

Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes

Role: collaborator

All 5 trials loaded